Quince Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -12.27M-89.70M-51.64M-31.39M-56.83M
Depreciation and Depletion 0.05M0.19M0.33M0.34M0.20M0.30M0.20M
Share-based Compensation 0.15M2.06M14.47M29.85M16.62M5.22M4.75M
Gains from Investment Securities -0.05M0.88M0.62M0.05M1.58M3.98M
Asset Writedowns and Impairment 0.14M0.07M
Cash from Operations -11.70M-33.28M-50.82M-62.93M-44.04M-18.29M-31.90M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.69M0.81M-0.64M-0.88M0.11M2.02M2.35M
Amortization of Deferred Charges 0.26M
Depreciation & Amortization (CF) 0.05M0.19M0.33M0.34M0.20M0.32M0.19M
Change in Working Capital
Change in Account Payables -0.02M2.58M0.48M1.36M-5.94M-0.29M0.93M
Change in Accured Expenses 0.27M4.86M7.38M-4.63M-6.66M-1.97M1.18M
Investing Activities
Capital Expenditures 0.21M0.06M0.05M0.18M0.13M0.16M0.26M
Sales of Property, Plant and Equipment 0.07M0.09M
Acquisitions 10.59M
Change in Acquisitions & Divestments 8.70M117.72M134.76M97.92M82.49M111.21M111.73M
Cash from Investing Activities -46.75M-17.75M-52.43M58.95M18.00M-5.76M21.91M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances 0.25M
Change in Capital Stock
Shares Issued 0.02M77.83M117.63M6.81M0.61M0.15M0.23M
Preferred Shares Issued 75.69M
Misc.
Cash from Financing Activities 75.93M77.37M118.88M6.81M0.71M0.14M-4.78M
Exchange Rate Effect 0.06M0.18M0.08M0.23M
Change in Cash 17.48M26.34M15.63M2.88M-25.14M-23.83M-14.54M
Free Cash Flow -11.91M-33.33M-50.87M-63.11M-44.17M-18.45M-32.16M
Net Cash Flow 17.48M26.34M15.63M2.83M-25.33M-23.91M-14.77M